HEADER HYDROLASE 21-APR-17 5NQR TITLE POTENT INHIBITORS OF NUDT5 SILENCE HORMONE SIGNALING IN BREAST CANCER COMPND MOL_ID: 1; COMPND 2 MOLECULE: ADP-SUGAR PYROPHOSPHATASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: 8-OXO-DGDP PHOSPHATASE,NUCLEAR ATP-SYNTHESIS PROTEIN NUDIX5, COMPND 5 NUCLEOSIDE DIPHOSPHATE-LINKED MOIETY X MOTIF 5,HNUDT5,YSA1H; COMPND 6 EC: 3.6.1.13,3.6.1.58,2.7.7.96; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NUDT5, NUDIX5, HSPC115; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS NUDIX, INHIBITOR, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR M.CARTER,P.STENMARK REVDAT 2 17-JAN-24 5NQR 1 REMARK REVDAT 1 31-JAN-18 5NQR 0 JRNL AUTH B.D.G.PAGE,N.C.K.VALERIE,R.H.G.WRIGHT,O.WALLNER,R.ISAKSSON, JRNL AUTH 2 M.CARTER,S.G.RUDD,O.LOSEVA,A.S.JEMTH,I.ALMLOF,J.FONT-MATEU, JRNL AUTH 3 S.LLONA-MINGUEZ,P.BARANCZEWSKI,F.JEPPSSON,E.HOMAN, JRNL AUTH 4 H.ALMQVIST,H.AXELSSON,S.REGMI,A.L.GUSTAVSSON,T.LUNDBACK, JRNL AUTH 5 M.SCOBIE,K.STROMBERG,P.STENMARK,M.BEATO,T.HELLEDAY JRNL TITL TARGETED NUDT5 INHIBITORS BLOCK HORMONE SIGNALING IN BREAST JRNL TITL 2 CANCER CELLS. JRNL REF NAT COMMUN V. 9 250 2018 JRNL REFN ESSN 2041-1723 JRNL PMID 29343827 JRNL DOI 10.1038/S41467-017-02293-7 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX DEV_1631 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.76 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.4 REMARK 3 NUMBER OF REFLECTIONS : 18626 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.183 REMARK 3 R VALUE (WORKING SET) : 0.180 REMARK 3 FREE R VALUE : 0.238 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.160 REMARK 3 FREE R VALUE TEST SET COUNT : 962 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 41.7701 - 4.1782 0.99 2676 127 0.1426 0.1785 REMARK 3 2 4.1782 - 3.3168 0.99 2546 149 0.1500 0.2002 REMARK 3 3 3.3168 - 2.8976 0.99 2573 145 0.1847 0.2791 REMARK 3 4 2.8976 - 2.6328 0.98 2503 145 0.2158 0.2731 REMARK 3 5 2.6328 - 2.4441 0.98 2507 148 0.2431 0.3381 REMARK 3 6 2.4441 - 2.3000 0.96 2472 126 0.2622 0.3197 REMARK 3 7 2.3000 - 2.1848 0.93 2387 122 0.2851 0.3569 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.310 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.200 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 3192 REMARK 3 ANGLE : 1.389 4353 REMARK 3 CHIRALITY : 0.042 483 REMARK 3 PLANARITY : 0.009 561 REMARK 3 DIHEDRAL : 13.357 1185 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5NQR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 21-APR-17. REMARK 100 THE DEPOSITION ID IS D_1200003159. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-DEC-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.92 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18626 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 41.800 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.6 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.30 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.2 REMARK 200 DATA REDUNDANCY IN SHELL : 2.80 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 3AC9 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 34.58 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.88 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M HEPES, PH 7.5, 300 MM NACL, 10% REMARK 280 GLYCEROL, AND 1 MM TCEP, VAPOR DIFFUSION, TEMPERATURE 291.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 55.79950 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 19.65150 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 55.79950 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 19.65150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6700 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16330 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -49.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLU A 2 REMARK 465 SER A 3 REMARK 465 GLN A 4 REMARK 465 GLU A 5 REMARK 465 PRO A 6 REMARK 465 THR A 7 REMARK 465 GLU A 8 REMARK 465 SER A 9 REMARK 465 SER A 10 REMARK 465 GLN A 11 REMARK 465 ASN A 12 REMARK 465 GLY A 13 REMARK 465 ALA A 209 REMARK 465 LYS A 210 REMARK 465 PRO A 211 REMARK 465 PHE A 212 REMARK 465 GLU A 213 REMARK 465 VAL A 214 REMARK 465 PRO A 215 REMARK 465 PHE A 216 REMARK 465 LEU A 217 REMARK 465 LYS A 218 REMARK 465 PHE A 219 REMARK 465 MET B 1 REMARK 465 GLU B 2 REMARK 465 SER B 3 REMARK 465 GLN B 4 REMARK 465 GLU B 5 REMARK 465 PRO B 6 REMARK 465 THR B 7 REMARK 465 GLU B 8 REMARK 465 SER B 9 REMARK 465 SER B 10 REMARK 465 GLN B 11 REMARK 465 ASN B 12 REMARK 465 GLY B 13 REMARK 465 ALA B 209 REMARK 465 LYS B 210 REMARK 465 PRO B 211 REMARK 465 PHE B 212 REMARK 465 GLU B 213 REMARK 465 VAL B 214 REMARK 465 PRO B 215 REMARK 465 PHE B 216 REMARK 465 LEU B 217 REMARK 465 LYS B 218 REMARK 465 PHE B 219 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 162 C - N - CA ANGL. DEV. = 13.6 DEGREES REMARK 500 PRO A 162 C - N - CD ANGL. DEV. = -29.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 55 -110.13 -128.43 REMARK 500 GLU A 56 40.23 -97.26 REMARK 500 ASP A 133 77.52 -162.82 REMARK 500 LEU A 136 -38.61 -140.20 REMARK 500 PRO A 160 62.12 -61.41 REMARK 500 LYS A 161 98.29 31.52 REMARK 500 PRO A 162 -115.07 11.68 REMARK 500 ASP A 164 -51.82 -141.08 REMARK 500 GLU A 189 -141.85 44.22 REMARK 500 LYS B 55 -116.49 -122.98 REMARK 500 GLU B 56 48.75 -102.56 REMARK 500 ASP B 133 77.93 -163.55 REMARK 500 LEU B 136 -35.32 -139.89 REMARK 500 ASP B 164 -55.10 -25.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 958 A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 958 A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 958 A 303 DBREF 5NQR A 1 219 UNP Q9UKK9 NUDT5_HUMAN 1 219 DBREF 5NQR B 1 219 UNP Q9UKK9 NUDT5_HUMAN 1 219 SEQRES 1 A 219 MET GLU SER GLN GLU PRO THR GLU SER SER GLN ASN GLY SEQRES 2 A 219 LYS GLN TYR ILE ILE SER GLU GLU LEU ILE SER GLU GLY SEQRES 3 A 219 LYS TRP VAL LYS LEU GLU LYS THR THR TYR MET ASP PRO SEQRES 4 A 219 THR GLY LYS THR ARG THR TRP GLU SER VAL LYS ARG THR SEQRES 5 A 219 THR ARG LYS GLU GLN THR ALA ASP GLY VAL ALA VAL ILE SEQRES 6 A 219 PRO VAL LEU GLN ARG THR LEU HIS TYR GLU CYS ILE VAL SEQRES 7 A 219 LEU VAL LYS GLN PHE ARG PRO PRO MET GLY GLY TYR CYS SEQRES 8 A 219 ILE GLU PHE PRO ALA GLY LEU ILE ASP ASP GLY GLU THR SEQRES 9 A 219 PRO GLU ALA ALA ALA LEU ARG GLU LEU GLU GLU GLU THR SEQRES 10 A 219 GLY TYR LYS GLY ASP ILE ALA GLU CYS SER PRO ALA VAL SEQRES 11 A 219 CYS MET ASP PRO GLY LEU SER ASN CYS THR ILE HIS ILE SEQRES 12 A 219 VAL THR VAL THR ILE ASN GLY ASP ASP ALA GLU ASN ALA SEQRES 13 A 219 ARG PRO LYS PRO LYS PRO GLY ASP GLY GLU PHE VAL GLU SEQRES 14 A 219 VAL ILE SER LEU PRO LYS ASN ASP LEU LEU GLN ARG LEU SEQRES 15 A 219 ASP ALA LEU VAL ALA GLU GLU HIS LEU THR VAL ASP ALA SEQRES 16 A 219 ARG VAL TYR SER TYR ALA LEU ALA LEU LYS HIS ALA ASN SEQRES 17 A 219 ALA LYS PRO PHE GLU VAL PRO PHE LEU LYS PHE SEQRES 1 B 219 MET GLU SER GLN GLU PRO THR GLU SER SER GLN ASN GLY SEQRES 2 B 219 LYS GLN TYR ILE ILE SER GLU GLU LEU ILE SER GLU GLY SEQRES 3 B 219 LYS TRP VAL LYS LEU GLU LYS THR THR TYR MET ASP PRO SEQRES 4 B 219 THR GLY LYS THR ARG THR TRP GLU SER VAL LYS ARG THR SEQRES 5 B 219 THR ARG LYS GLU GLN THR ALA ASP GLY VAL ALA VAL ILE SEQRES 6 B 219 PRO VAL LEU GLN ARG THR LEU HIS TYR GLU CYS ILE VAL SEQRES 7 B 219 LEU VAL LYS GLN PHE ARG PRO PRO MET GLY GLY TYR CYS SEQRES 8 B 219 ILE GLU PHE PRO ALA GLY LEU ILE ASP ASP GLY GLU THR SEQRES 9 B 219 PRO GLU ALA ALA ALA LEU ARG GLU LEU GLU GLU GLU THR SEQRES 10 B 219 GLY TYR LYS GLY ASP ILE ALA GLU CYS SER PRO ALA VAL SEQRES 11 B 219 CYS MET ASP PRO GLY LEU SER ASN CYS THR ILE HIS ILE SEQRES 12 B 219 VAL THR VAL THR ILE ASN GLY ASP ASP ALA GLU ASN ALA SEQRES 13 B 219 ARG PRO LYS PRO LYS PRO GLY ASP GLY GLU PHE VAL GLU SEQRES 14 B 219 VAL ILE SER LEU PRO LYS ASN ASP LEU LEU GLN ARG LEU SEQRES 15 B 219 ASP ALA LEU VAL ALA GLU GLU HIS LEU THR VAL ASP ALA SEQRES 16 B 219 ARG VAL TYR SER TYR ALA LEU ALA LEU LYS HIS ALA ASN SEQRES 17 B 219 ALA LYS PRO PHE GLU VAL PRO PHE LEU LYS PHE HET 958 A 301 29 HET 958 A 302 29 HET 958 A 303 29 HETNAM 958 8-(DIMETHYLAMINO)-1,3-DIMETHYL-7-[[5-(3-METHYLPHENYL)- HETNAM 2 958 1,3,4-OXADIAZOL-2-YL]METHYL]PURINE-2,6-DIONE HETSYN 958 TH5427 FORMUL 3 958 3(C19 H21 N7 O3) FORMUL 6 HOH *174(H2 O) HELIX 1 AA1 THR A 104 GLY A 118 1 15 HELIX 2 AA2 ASP A 152 ALA A 156 5 5 HELIX 3 AA3 ASP A 177 GLU A 188 1 12 HELIX 4 AA4 ASP A 194 ASN A 208 1 15 HELIX 5 AA5 PRO B 85 GLY B 88 5 4 HELIX 6 AA6 THR B 104 GLY B 118 1 15 HELIX 7 AA7 ASP B 152 ARG B 157 1 6 HELIX 8 AA8 ASP B 177 GLU B 189 1 13 HELIX 9 AA9 ASP B 194 ALA B 207 1 14 SHEET 1 AA1 3 TYR A 16 GLU A 25 0 SHEET 2 AA1 3 VAL A 29 MET A 37 -1 O THR A 35 N SER A 19 SHEET 3 AA1 3 THR A 43 ARG A 51 -1 O TRP A 46 N THR A 34 SHEET 1 AA2 4 ALA A 96 LEU A 98 0 SHEET 2 AA2 4 GLY A 61 GLN A 69 -1 N VAL A 62 O GLY A 97 SHEET 3 AA2 4 CYS A 76 ARG A 84 -1 O CYS A 76 N LEU A 68 SHEET 4 AA2 4 VAL A 168 PRO A 174 -1 O ILE A 171 N LEU A 79 SHEET 1 AA3 6 ASP A 122 CYS A 131 0 SHEET 2 AA3 6 THR A 140 ASN A 149 -1 O THR A 147 N ASP A 122 SHEET 3 AA3 6 GLY A 61 GLN A 69 1 N GLN A 69 O ILE A 148 SHEET 4 AA3 6 CYS A 76 ARG A 84 -1 O CYS A 76 N LEU A 68 SHEET 5 AA3 6 GLY A 89 GLU A 93 -1 O CYS A 91 N GLN A 82 SHEET 6 AA3 6 LEU A 191 VAL A 193 1 O THR A 192 N ILE A 92 SHEET 1 AA4 3 TYR B 16 GLU B 25 0 SHEET 2 AA4 3 VAL B 29 MET B 37 -1 O LEU B 31 N SER B 24 SHEET 3 AA4 3 THR B 43 ARG B 51 -1 O TRP B 46 N THR B 34 SHEET 1 AA5 4 ALA B 96 LEU B 98 0 SHEET 2 AA5 4 GLY B 61 GLN B 69 -1 N VAL B 62 O GLY B 97 SHEET 3 AA5 4 CYS B 76 ARG B 84 -1 O CYS B 76 N LEU B 68 SHEET 4 AA5 4 GLU B 169 PRO B 174 -1 O LEU B 173 N ILE B 77 SHEET 1 AA6 6 ASP B 122 CYS B 131 0 SHEET 2 AA6 6 THR B 140 ASN B 149 -1 O THR B 147 N ASP B 122 SHEET 3 AA6 6 GLY B 61 GLN B 69 1 N GLN B 69 O ILE B 148 SHEET 4 AA6 6 CYS B 76 ARG B 84 -1 O CYS B 76 N LEU B 68 SHEET 5 AA6 6 GLY B 89 GLU B 93 -1 O GLU B 93 N VAL B 80 SHEET 6 AA6 6 THR B 192 VAL B 193 1 O THR B 192 N TYR B 90 SITE 1 AC1 12 TRP A 28 ARG A 51 ASP A 60 GLY A 61 SITE 2 AC1 12 ARG A 84 ILE A 141 958 A 302 HOH A 407 SITE 3 AC1 12 HOH A 456 THR B 45 TRP B 46 GLU B 47 SITE 1 AC2 11 TRP A 28 ARG A 51 LEU A 98 MET A 132 SITE 2 AC2 11 ILE A 141 958 A 301 HOH A 407 HOH A 456 SITE 3 AC2 11 THR B 45 TRP B 46 GLU B 47 SITE 1 AC3 13 THR A 45 TRP A 46 GLU A 47 GLY A 135 SITE 2 AC3 13 HOH A 406 HOH A 472 TRP B 28 ARG B 51 SITE 3 AC3 13 ASP B 60 GLY B 61 ALA B 96 ILE B 141 SITE 4 AC3 13 HOH B 363 CRYST1 111.599 39.303 98.723 90.00 122.22 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008961 0.000000 0.005646 0.00000 SCALE2 0.000000 0.025443 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011972 0.00000